Several clinical trials have addressed the role of adjuvant chemotherapy following neoadjuvant chemoradiation and surgery for rectal cancer. The recently published EORTC 22921 study adds further debate to the merits of adjuvant chemotherapy in this setting.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo
Journal of Experimental & Clinical Cancer Research Open Access 04 September 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bosset, J. F. et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N. Engl. J. Med. 355, 1114–1123 (2006).
Bosset, J. F. et al. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. Lancet Oncol. 15, 184–190 (2014).
Collette, L. et al. Patients with curative resection of cT3–4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group. J. Clin. Oncol. 25, 4379–4386 (2007).
O'Connell, M. J. et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J. Clin. Oncol. 15, 246–250 (1997).
André, T. et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J. Clin. Oncol. 27, 3109–3116 (2009).
Cionini, L., Sainato, A. & De Paoli, A. Final results of randomised trial on adjuvant chemotherapy after preoperative chemoradiation in rectal cancer [abstract]. Radiother. Oncol. 96 (Suppl. 1), S113–S114 (2010).
Breugom, A. J., van den Broek, C. B. M. & van Gijn, W. The value of adjuvant chemotherapy in rectal cancer patients after preoperative radiotherapy or chemotherapy followed by TME-surgery: the PROCTOR/SCRIPT study [abstract]. Eur. J. Cancer 49 (Suppl. 2), S539 (2013).
Glynne-Jones, R., Counsell, M., Meadows, H. & Sebag-Montefiore, D. Chronicle: a phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine/ oxaliplatin versus control [abstract]. Ann. Oncol. 24 (Suppl. 4), iv18 (2013).
Fernandez-Martos, C. et al. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo Cancer de Recto 3 study. J. Clin. Oncol. 28, 859–865 (2010).
Fernandez-Martos, C. et al. Chemoradiation (CRT) followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant CRT and surgery for locally advanced rectal cancer: results of the spanish GCR-3 randomized phase II trial after a median follow-up of 5 years [abstract]. J. Clin. Oncol. 32 (Suppl. 3), a383 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Palta, M., Czito, B. & Willett, C. Adjuvant chemotherapy for rectal cancer—an unresolved issue. Nat Rev Clin Oncol 11, 182–184 (2014). https://doi.org/10.1038/nrclinonc.2014.43
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrclinonc.2014.43
This article is cited by
-
Early closure compared to late closure of temporary ileostomy in rectal cancer: a randomized controlled trial study
Langenbeck's Archives of Surgery (2023)
-
Magnetic Amine-Functionalized UiO-66 for Oxaliplatin Delivery to Colon Cancer Cells: In Vitro Studies
Journal of Cluster Science (2022)
-
Autophagy inhibition sensitizes WYE-354-induced anti-colon cancer activity in vitro and in vivo
Tumor Biology (2016)
-
Pre-clinical characterization of 4SC-202, a novel class I HDAC inhibitor, against colorectal cancer cells
Tumor Biology (2016)
-
Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo
Journal of Experimental & Clinical Cancer Research (2015)